PK, S., V, V., A, C., AR, N., SV, R., PM, B., . . . H, P. (2026). Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitus. Metabolism open, 30, 100476. https://doi.org/10.1016/j.metop.2026.100476
Chicago Style (17th ed.) CitationPK, Sharma, et al. "Efficacy and Safety of Novel Formulation of Semaglutide Injection: A Multicentre, Randomized, Comparative, Active Controlled, Phase 3 Study in Comparison with Reference Biologic in Indian Patients with Type 2 Diabetes Mellitus." Metabolism Open 30 (2026): 100476. https://doi.org/10.1016/j.metop.2026.100476.
MLA (9th ed.) CitationPK, Sharma, et al. "Efficacy and Safety of Novel Formulation of Semaglutide Injection: A Multicentre, Randomized, Comparative, Active Controlled, Phase 3 Study in Comparison with Reference Biologic in Indian Patients with Type 2 Diabetes Mellitus." Metabolism Open, vol. 30, 2026, p. 100476, https://doi.org/10.1016/j.metop.2026.100476.